文献速递心力衰竭与心肌病

射血分数保留或降低的心力衰竭中高密度脂蛋白颗粒亚组分的差异

High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

在CATHGEN导管队列中,比较HFrEF(n=782)、HFpEF(n=1004)与无HF(n=4742)患者的HDL-P亚组分。HFrEF平均HDL-P尺寸大于HFpEF,两者均大于无HF;小HDL-P和总HDL-P浓度在HFrEF低于HFpEF,两者均低于无HF。总HDL-P和小HDL-P与不良事件时间呈负相关,且在调整14项临床协变量后持续存在。

要点

  • HFrEF患者平均HDL-P尺寸大于HFpEF,两者均大于无HF。
  • 小HDL-P和总HDL-P浓度在HFrEF低于HFpEF,两者均低于无HF。
  • 总HDL-P和小HDL-P与不良事件时间负相关,独立于传统危险因素。

核心结论

  • HDL-P亚组分紊乱在HFrEF比HFpEF更严重,且独立关联不良结局。

研究设计与样本

  • 在CATHGEN生物库中识别HFrEF(n=782)、HFpEF(n=1004)和无HF(n=4742)患者。
  • 对导管术时获取的冷冻空腹血浆进行核磁共振脂蛋白 profiling。
  • 采用多变量协方差分析比较HDL-P亚组分,Cox比例风险模型评估与死亡或主要不良心脏事件时间的关联。

主要发现

  • 平均HDL-P尺寸在HFrEF大于HFpEF,两者均大于无HF(所有两两比较p<0.0001)。
  • 小HDL-P和总HDL-P浓度在HFrEF低于HFpEF,两者均低于无HF(所有两两比较p≤0.0002)。
  • 在HFrEF和HFpEF中,总HDL-P和小HDL-P与不良事件时间呈负相关。
  • 上述关联在调整14项临床协变量(包括HDL胆固醇含量、冠心病和炎症标志物GlycA)后持续存在。
  • 在采用替代LVEF定义或更严格纳入标准(舒张功能障碍或LVEDP阈值)的敏感性分析中,结果持续存在。

临床怎么用

  • HDL-P亚组分可能有助于细化心衰风险分层。
  • 总HDL-P和小HDL-P浓度降低提示不良事件风险增加,可辅助风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Circulating high-density lipoprotein particle (HDL-P) subfractions impact atherogenesis, inflammation, and endothelial function, all of which are implicated in the pathobiology of heart failure (HF). OBJECTIVES: The authors sought to identify key differences in plasma HDL-P subfractions between patients with HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) to determine their prognostic utility. METHODS: Patients with HFrEF (n = 782), HFpEF (n = 1,004), and no HF (n = 4,742) were identified in the CATHGEN (Catheterization Genetics) biorepository of sequential patients undergoing cardiac catheterization. Nuclear magnetic resonance-based lipoprotein profiling was performed on frozen fasting plasma obtained at catheterization. The authors used multivariable analysis of covariance to compare high-density lipoprotein particle (HDL-P) subfractions across groups, and Cox proportional hazards modeling to determine associations between HDL-P subfractions and time to death or major adverse cardiac events. RESULTS: Mean HDL-P size was greater in HFrEF than HFpEF, both of which were greater than in no HF (all 2-way p < 0.0001). By contrast, concentrations of small HDL-P and total HDL-P were lesser in HFrEF than HFpEF, which were both lesser than no HF (all 2-way p ≤ 0.0002). In both HFrEF and HFpEF, total HDL-P and small HDL-P were inversely associated with time to adverse events. These findings persisted after adjustment for 14 clinical covariates (including high-density lipoprotein cholesterol content, coronary artery disease, and the inflammatory biomarker GlycA), and in sensitivity analyses featuring alternate left ventricular ejection fraction definitions, or stricter inclusion criteria with diastolic dysfunction or left ventricular end-diastolic pressure thresholds. CONCLUSIONS: In the largest analysis of HDL-P subfractions in HF to date, derangements in HDL-P subfractions were identified that were more severe in HFrEF than HFpEF and were independently associated with adverse outcomes. These data may help refine risk assessment and provide new insights into the complex interaction of HDL and HF pathophysiology.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Hunter WG, McGarrah RW, Kelly JP, et al. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction. J Am Coll Cardiol. 2019. PMID: 30654890. doi:10.1016/j.jacc.2018.10.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。